Extracorporeal blood treatment apparatus and method of setting an extracorporeal blood treatment

US11007309B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11007309-B2
Application numberUS-201916522016-A
CountryUS
Kind codeB2
Filing dateJul 25, 2019
Priority dateSep 28, 2012
Publication dateMay 18, 2021
Grant dateMay 18, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

It is described an extracorporeal blood treatment apparatus (1) with a user interface (12) device capable configuring and allowing execution of one or more isolated ultrafiltration tasks during the course of a dialysis treatment. The extracorporeal blood treatment apparatus (1) is controlled in a normal mode, where dialysis fluid is fed to the blood treatment unit (2), and in an isolated ultrafiltration mode, where fresh dialysis fluid is no longer fed to the blood treatment unit (2).

First claim

Opening claim text (preview).

The invention claimed is: 1. An extracorporeal blood treatment apparatus comprising: a blood treatment unit having a primary chamber configured to receive blood of a patient to be treated, and a secondary chamber separated from the primary chamber by a semi-permeable membrane; an hydraulic circuit having a fresh fluid line configured to connect to an inlet of the secondary chamber, and a spent fluid line configured to connect to an outlet of said secondary chamber and configured to remove spent liquid from the secondary chamber and convey it to at least one waste, a control unit operably connected to the hydraulic circuit and configured to control the hydraulic circuit to selectively operate in a normal mode, where the fresh fluid line is connected to the inlet of the secondary chamber of the treatment unit and conveys fresh treatment liquid to the secondary chamber, and wherein the control unit is further configured to control the hydraulic circuit to selectively operate in an isolated ultrafiltration mode, where the fresh fluid line does not convey fresh treatment liquid to the secondary chamber, the control unit further configured to execute a setup phase before starting treatment, the setup phase comprising: receiving at least two general setup values selected from: a prescription value for a total treatment time during which the patient is to be submitted to blood treatment, a prescription value for a total patient fluid removal to be achieved by the end of total treatment time, a prescription value for an average patient fluid removal rate to be kept across total treatment time; receiving instructions to execute a selected plurality of isolated ultrafiltration tasks during the total treatment time, wherein the control unit is configured to: receive, for each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks, values of at least two isolated ultrafiltration parameters selected from: an isolated ultrafiltration time, which is a time interval during which the apparatus is requested to operate in said isolated ultrafiltration mode, an isolated ultrafiltration volume, which is a volume of fluid to be removed from the patient while the apparatus is requested to operate in said isolated ultrafiltration mode, an isolated ultrafiltration rate which is a rate of fluid removal from the patient while the apparatus is requested to operate in said isolated ultrafiltration mode; determining, during the setup phase, at least one of: a remaining treatment time based on said isolated ultrafiltration time of each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks, the remaining treatment time being a treatment time during which the patient shall be submitted to blood treatment with the apparatus operating in normal mode after operation in isolated ultrafiltration mode, a remaining patient fluid removal based on said isolated ultrafiltration volume of each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks, the remaining patient fluid removal being a volume of fluid to be extracted from the patient with the apparatus operating in normal mode after operation in isolated ultrafiltration mode, a remaining patient fluid removal rate based on said isolated ultrafiltration rate of each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks, the remaining patient fluid removal rate being a rate of fluid to be extracted from the patient with the apparatus operating in normal mode after operation in isolated ultrafiltration mode; wherein the control unit is configured to control the hydraulic circuit to operate in isolated ultrafiltration mode during the total treatment time corresponding to the selected plurality of isolated ultrafiltration tasks and based on the values of at the least two isolated ultrafiltration parameters received for each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks; wherein, when the hydraulic circuit is operating in the isolated ultrafiltration mode, the control unit is further configured to control the hydraulic circuit to switch from operating in the isolated ultrafiltration mode to the normal mode upon the first of: passage of all of said isolated ultrafiltration time; withdrawal from a patient of said isolated ultrafiltration volume; or receipt of a command from a user interface connected to the control unit indicating to end the isolated ultrafiltration mode; and wherein, when operating the hydraulic circuit in the normal mode after operating in the isolated ultrafiltration mode, the control unit is configured to operate the hydraulic circuit in the normal mode based on the values of two of: the remaining treatment time, the remaining patient fluid removal, and the remaining patient fluid removal rate determined during the setup phase for each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks. 2. An apparatus according to claim 1 , wherein during the setup phase, the control unit is configured to: receive, as two general setup values, the prescription value for the total treatment time and the prescription value for the total patient fluid removal; receive, as two isolated ultrafiltration parameters for each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks, the isolated ultrafiltration time and the isolated ultrafiltration volume; determine the remaining treatment time at least based on the isolated ultrafiltration time of each isolated ultrafiltration task of each of the plurality of isolated ultrafiltration tasks and on said prescription value for a total treatment time; determine the remaining patient fluid removal based on the isolated ultrafiltration volume of each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks and on the prescription value for a total patient fluid removal; wherein causing the hydraulic circuit to operate in the isolated ultrafiltration mode for each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks comprises controlling at least one ultrafiltration actuator of the hydraulic circuit based on the isolated ultrafiltration time and the isolated ultrafiltration volume for each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks; and wherein causing the hydraulic circuit to operate in the normal mode after operating the hydraulic circuit in isolated ultrafiltration mode for each isolated ultrafiltration task of the plurality of isolated ultrafiltration tasks comprises controlling at least one ultrafiltration actuator of the hydraulic circuit based on the values of the remaining treatment time and the remaining patient fluid removal. 3. An apparatus according to claim 2 , wherein the control unit is configured to: calculate the value of the remaining patient fluid removal rate based on the following equation: remaining patient fluid removal rate=(remaining patient fluid removal)/(remaining treatment time), and control at least one ultrafiltration actuator of the hydraulic circuit in the normal mode based on the calculated value of the remaining patient fluid removal rate. 4. An apparatus according to claim 1 , wherein receiving the value of the isolated ultrafiltration time comprises either receiving a prefixed value pre-stored in a memory connected to the control unit, or receiving an entered value for the isolated ultrafiltration time via a data entry unit connected to the control unit. 5. An apparatus according to claim 1 , wherein receiving the value of the isolated ultrafiltration volume comprises either receiving a prefixed value pre-stored in a memory connected to the control unit, or receiving an entered value for the isolated ultrafiltration volume

Assignees

Inventors

Classifications

  • A61M1/16Primary

    with membranes · CPC title

  • Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches · CPC title

  • upstream of the filter · CPC title

  • Regulation parameters · CPC title

  • by measuring the filtrate rate or volume · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11007309B2 cover?
It is described an extracorporeal blood treatment apparatus (1) with a user interface (12) device capable configuring and allowing execution of one or more isolated ultrafiltration tasks during the course of a dialysis treatment. The extracorporeal blood treatment apparatus (1) is controlled in a normal mode, where dialysis fluid is fed to the blood treatment unit (2), and in an isolated ultraf…
Who is the assignee on this patent?
Gambro Lundia Ab
What technology area does this patent fall under?
Primary CPC classification A61M1/16. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).